Enovis reported an 11% increase in fourth-quarter net sales, reaching $455 million, with 8% organic growth. Net income from continuing operations was $3 million, or $0.05 per share, and adjusted earnings per diluted share were $0.79. The company's full-year net sales grew 9% to $1.7 billion, with an adjusted EBITDA margin increase.
Fourth-quarter sales grew by 11%, with organic growth of 8%.
Net income from continuing operations was $0.05 per share, with adjusted earnings per diluted share of $0.79.
Recon sales grew by 18%, with 11% organic sales growth.
P&R sales grew by 8%, with 6% organic sales growth.
Enovis expects revenue to approximate $2.05-2.15 billion, including $290-300 million from the Lima acquisition. Adjusted EBITDA is forecasted to be $365-$380 million, inclusive of $70-75 million from Lima. Full-year adjusted earnings per diluted share are expected to be in the range of $2.50-$2.65.